In an interview with Benzinga, Oragenics (NYSE: OGEN) CEO John Bonfiglio discussed the company’s business and opportunities that lie ahead.
Bonfiglio started by explaining Oragenics’ most active business line: the development of a new...
By Trevor Lowenthal:
With the growing problem of antibiotic resistance and the dire need for viable anti-infective therapies, we continue to investigate and report on antibiotic developers pioneering innovative technologies to address this public...
Oragenics (NYSE MKT: OGEN) today announced that in view of
the unusual market activity in the Company's stock, the NYSE MKT has contacted the Company in accordance with its usual
practice. The Company stated that its policy is not...
(NYSE: OGEN), a leader in the development of novel, effective antibiotics
and oral care probiotics, and Intrexon Corporation (NYSE: XON), a leader in
synthetic biology, today announced the establishment of an Exclusive...
Clearswift, das in Großbritannien ansässige Unternehmen für
Informationssicherheit, hat mit ONI, dem portugiesischen Anbieter von
Kommunikationslösungen, einen Vertrag abgeschlossen, um den
Geschäftskunden von ONI seine...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
Hi Marcel,Thanks for your offer we love to get beta testers! We are some way off pzeaonslierd dashboards, but we might have an export to SD in the interim. We'll update the blog when we have more info.